Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.

  1. Interactive E-Learning to Promote Successful Postsecondary Employment Outcomes for Students with Intellectual Disabilities

    SBC: 3-C Institute for Social Development, Inc.            Topic: NA

    This project creates a Web-based Occupational Resource Kit (W.O.R.K.), the first self-paced, adaptive job skills intervention designed specifically to meet the learning styles and social-emotional needs of students with intellectual disabilities. W.O.R.K. enhances students’ preparedness for postsecondary employment, optimizing the likelihood of success in the workforce following completion of hi ...

    SBIR Phase II 2015 Department of Health and Human Services
  2. CHEMOENZYMATIC SYNTHESIS OF HEPARAN SULFATE OLIGOSACCHARIDES

    SBC: Glycan Therapeutics LLC            Topic: NCI

    The goal of this contract is to synthesize a heparan sulfate HS library consisting of structurally homogeneous oligosaccharides in response to an SBIR contract call from NCl Chemically Defined Glycan Libraries The Contractor specializes in the synthesis of structurally diverse HS oligosaccharides The Contractor has built an innovative chemoenzymatic method for Glycan synthesis Polymeri ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  3. IGF OT IGF Fluorescent Nanodiamonds for In Vitro and In Vivo Biological Imaging SBIR Topic Phase II

    SBC: Adamas Nanotechnologies, Inc.            Topic: NHLBI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  4. IGF OT IGF ARISE AN ONLINE RELAPSE PREVENTION TOOL FOR SUBSTANCE ABUSERS N DA POP SEPTEMBER SEPTEMBER SUPPLEMENTAL W IN SCOPE

    SBC: 3-C Institute for Social Development, Inc.            Topic: NIDA

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  5. C2E2-An Orally Administered Radionuclide Decorporation Agent

    SBC: Capture Pharmaceuticals, Inc.            Topic: R

    DESCRIPTION provided by applicant Capture Pharmaceuticals Inc is developing a drug called C E for treatment of individuals who have been contaminated by radioactive transuranic elements either by accident or following a nuclear terrorism event C E is a radionuclide decorporation agent that works by binding these elements in the bloodstream and enhancing their elimination before they can b ...

    SBIR Phase II 2015 Department of Health and Human Services
  6. Development of novel anti-biofilm compounds for treating chronic wounds

    SBC: AGILE SCIENCES, INC.            Topic: NIAID

    DESCRIPTION provided by applicant Chronic wounds that fail to respond to traditional therapeutic interventions afflict millions of people each year and direct costs associated with treating these wounds are estimated at $ billion annually in the U S alone Eradication of pathogenic bacteria that have colonized chronic wounds is complicated by the propensity of these bacteria to form biof ...

    SBIR Phase II 2015 Department of Health and Human Services
  7. Improving Interlock Compliance with Computerized Education and Monitoring Systems

    SBC: AXXESS UNLIMITED, LLC            Topic: 400

    DESCRIPTION provided by applicant All States have enacted laws providing for alcohol ignition interlocks as a sanction for impaired driving Going forward interlock programs may become as widely used with impaired drivers as license suspension even though they are more time consuming and expensive for the government to manage Although the extra expense of managing interlock programs is jus ...

    SBIR Phase II 2015 Department of Health and Human Services
  8. A crosslinked cartilage-derived matrix for cartilage tissue engineering

    SBC: Cytex Therapeutics, Inc.            Topic: NIAMS

    DESCRIPTION provided by applicant The overall goal of the present study is to resurface a diseased femoral condyle in an ovine model of unicompartmental osteoarthritis OA For patients suffering from unicompartmental OA of the knee unicondylar knee arthroplasty UKA is an available first line treatment option that provides many potential advantages over more common total knee replacement p ...

    SBIR Phase II 2015 Department of Health and Human Services
  9. Small molecules as antibiotic potentiating agents against multi-drug resistant Gram-negative infections

    SBC: AGILE SCIENCES, INC.            Topic: R

    DESCRIPTION provided by applicant Antibiotic resistance has been declared one of the three greatest threats to human health by the World Health Organization Infections caused by multi drug resistant MDR bacterial pathogens create substantial health and economic impacts on society due to the lack of effective therapeutic options created by the rapid acquisition of resistance and stagnant anti ...

    SBIR Phase II 2015 Department of Health and Human Services
  10. Coordinated Treatment of Addiction to Prescription Pain Medications

    SBC: Clinical Tools, Inc            Topic: R44

    DESCRIPTION provided by applicant In more than million people reported using prescription pain medications opioids non medically without a prescription and million people reported using prescription painkillers non medically for the first time In o people older than initiated illicit drug use via non medical use of prescription drugs Each year the prob ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government